Tenax Therapeutics
Patents, Design & Utilities
Last updated:
List of all Tenax Therapeutics patents 4 in total
| Status | Patent |
|---|---|
Application | Utility: PHARMACEUTICAL COMPOSITIONS FOR SUBCUTANEOUS ADMINISTRATION OF LEVOSIMENDAN Filling date: 26 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HFpEF) Filling date: 26 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HFpEF) Filling date: 26 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: Pharmaceutical Compositions for Subcutaneous Administration of Levosimendan Filling date: 26 Sep 2025 Issue date: 22 Oct 2020 |
Showing 1 to 4 of 4 patents.